# Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection

> **NCT04930900** · PHASE1 · COMPLETED · sponsor: **ARS Pharmaceuticals, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Upper Respiratory Tract Infection

## Interventions

- **DRUG:** ARS-1 with URTI
- **DRUG:** ARS-1 without URTI

## Key facts

- **NCT ID:** NCT04930900
- **Lead sponsor:** ARS Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-09
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-07-25
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930900, "Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04930900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*